Syros Pharmaceuticals News - SYRS

Company Name	Stock Ticker Symbol	Market	Type
Syros Pharmaceuticals Inc	SYRS	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.33	-7.08%	4.33	00:00:01

Open Price	Low Price	High Price	Close Price	Prev Close
4.57	4.05	4.65	4.14	4.66

more quote information »

Recent News

Date	Time	Source	Heading
12/08/2023	16:23	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/06/2023	16:00	EDGAR2	Form 144 - Report of proposed sale of securities
12/06/2023	07:05	EDGAR2	Form 8-K - Current report
12/06/2023	07:00	BW	Syros Announces Encouraging Initial Data from Randomized..
12/05/2023	17:28	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/21/2023	07:30	BW	Syros to Participate in Upcoming Investor Conferences
11/14/2023	07:30	BW	Syros Reports Third Quarter 2023 Financial Results and..
11/14/2023	06:47	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/2023	07:30	BW	Syros to Report Third Quarter 2023 Financial Results on..
11/02/2023	16:53	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/02/2023	16:52	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/02/2023	16:52	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/02/2023	16:51	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/20/2023	16:15	EDGAR2	Form SC 13D - General statement of acquisition of beneficial..
10/02/2023	08:49	EDGAR2	Form 8-K - Current report
10/02/2023	08:45	BW	Syros Announces Planned CEO Leadership Transition and..
9/07/2023	16:30	BW	Syros Reports Inducement Grants Under Nasdaq Listing Rule..
8/11/2023	16:30	EDGAR2	Form 8-K - Current report
8/08/2023	07:30	BW	Syros Reports Second Quarter 2023 Financial Results and..
8/08/2023	06:53	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/04/2023	16:30	BW	Syros Reports Inducement Grants Under Nasdaq Listing Rule..
8/02/2023	16:21	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/01/2023	07:30	BW	Syros to Report Second Quarter 2023 Financial Results on..
7/31/2023	16:12	EDGAR2	Form 144 - Report of proposed sale of securities
7/21/2023	16:36	EDGAR2	Form 8-K - Current report
7/18/2023	20:27	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/17/2023	16:00	EDGAR2	Form 144 - Report of proposed sale of securities
7/05/2023	16:30	BW	Syros Reports Inducement Grants Under Nasdaq Listing Rule..
6/08/2023	07:30	BW	Syros to Present at Sidoti June 2023 Virtual Small-Cap..
6/01/2023	16:30	BW	Syros Reports Inducement Grants Under Nasdaq Listing Rule..
5/25/2023	17:05	BW	Syros Presents Data from Phase 1/1b Clinical Trial of..
5/10/2023	07:30	BW	Syros Reports First Quarter 2023 Financial Results and..
5/09/2023	07:00	BW	Syros to Present at JMP Securities 2023 Life Sciences..
5/03/2023	07:30	BW	Syros to Report First Quarter 2023 Financial Results on..
5/02/2023	07:00	BW	Syros Reports Inducement Grants Under Nasdaq Listing Rule..
3/02/2023	07:30	BW	Syros Reports Fourth Quarter and Full Year 2022 Financial..
2/28/2023	07:30	BW	Syros to Participate in Upcoming Investor Conferences in..
2/23/2023	07:30	BW	Syros to Report Fourth Quarter and Full Year 2022 Financial..
2/09/2023	16:05	BW	Syros Reports Inducement Grants Under Nasdaq Listing Rule..
1/26/2023	07:00	BW	Syros Receives Fast Track Designation from the FDA for..
1/09/2023	07:00	BW	Syros Announces Clinical Updates and 2023 Strategic..
12/23/2022	16:05	BW	Syros Reports Inducement Grants Under Nasdaq Listing Rule..
12/12/2022	07:30	BW	Syros Pharmaceuticals Announces Publication in Blood..
12/12/2022	00:30	TRMN	Analysts Are Bullish on Top Healthcare Stocks: Kura Oncology..
12/10/2022	18:45	TRMN	Brookline Capital Markets Keeps Their Buy Rating on Syros..
12/10/2022	10:00	BW	Syros Presents Safety Lead-in Data from SELECT-AML-1 Trial..